Work

Cellular Inhibition of Checkpoint Kinase 2 (Chk2) and Potentiation of Camptothecins and Radiation by the Novel Chk2 Inhibitor PV1019 [7-Nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]

Year: 2009

Type: article

Source: Journal of Pharmacology and Experimental Therapeutics

DOI: 10.1124/jpet.109.154997

Authors: Andrew G. Jobson, George T. Lountos, Philip L. Lorenzi, Jenny Llamas, John Connelly, David Cerna, Joseph E. Tropea, Akikazu Onda, Gabriele Zoppoli, Sudhir Kondapaka, Guangtao Zhang, Natasha J. Caplen, John H. Cardellina, Stephen S. Yoo, Anne Monks, Christopher Self, David S. Waugh, Robert H. Shoemaker, Yves Pommier

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Provid Pharmaceuticals (United States), National Cancer Institute, National Cancer Institute

Language: English

Topic: DNA Repair Mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Energy, National Institutes of Health, Office of Science, National Heart, Lung, and Blood Institute, National Cancer Institute, Basic Energy Sciences, Argonne National Laboratory

OpenAlex ID: W2117389132

FWCI: 2.285

Cites: 41

Cited by: 95

Related to: 10